Olivia Ferro is the Co-Founder and CEO of SheMed, a company she co-founded with a passion for both health and business. Launched in the UK in December 2024, SheMed aims to challenge the status quo in women's healthcare. The company created the country's first female-focused GLP-1 programme, designed around the science and biology that shape women's metabolic and hormonal health. Her mission with SheMed is to deliver long-term, clinically led care that prioritizes women's health.